Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-28 | Dr. Dilly served as Chief Executive Officer of Aimmune Therapeutics, PhotoThera, Inc., and held management positions at Genentech and SmithKline Beecham. He has a medical degree and a Ph.D. in cardiac physiology. |
| 2023-04-27 | Dr. Dilly holds an M.B.B.S. from the University of London in the U.K. and a Ph.D. in cardiac physiology from the University of London. |
| 2024-04-25 | Dr. Dilly holds an M.B.B.S. from the University of London in the U.K. and a Ph.D. in cardiac physiology from the University of London. |
| Filing Date | Source Excerpt |
|---|---|
| 2011-04-21 | Stephen G. Dilly, M.B.B.S., Ph.D., age 51, has served as a member of our Board of Directors since March 2010 and is a member of the Audit Committee and is the Chairman of the Clinical Review Committee. The following table shows his total compensation: $224,730. |
| 2012-04-25 | Stephen G. Dilly, M.B.B.S., Ph.D., age 52, has served as a member of our Board of Directors since March 2010 and is a member of the Audit Committee and is the Chairman of the Clinical Review Committee. |
| 2013-04-25 | Stephen G. Dilly, M.B.B.S., Ph.D., age 53, has served as a member of our Board of Directors since March 2010... The Audit Committee currently consists of four directors: Mr. Cleveland, Dr. Dilly, Dr. Mento and Ms. Ramasastry... The Clinical Review Committee currently consists of three directors: Dr. Dilly, Mr. Lanphier and Ms. Ramasastry. Dr. Dilly serves as the Chairman of this committee... The following table sets forth certain information regarding the compensation of each non-employee director for service as a member of the Board of Directors during 2012. Stephen G. Dilly, M.B.B.S., PhD. 52,500 Fees Earned or Paid in Cash, 35,398 Option Awards, Total 87,898. |
| 2014-03-11 | Stephen G. Dilly, M.B.B.S., Ph.D., age 54, has served as a member of our Board of Directors since March 2010. Dr. Dilly serves as the Chairman of the Clinical Review Committee. The Audit Committee currently consists of four directors: Mr. Cleveland, Dr. Dilly, Dr. Mento and Ms. Ramasastry. |
| 2015-04-28 | Stephen G. Dilly, M.B.B.S., Ph.D., age 55, has served as a member of our Board of Directors since March 2010. The Clinical Review Committee currently consists of three directors: Dr. Dilly, Dr. Mento and Mr. Lanphier. Dr. Dilly serves as the Chairman of this committee. The Audit Committee currently consists of three directors: Mr. Cleveland, Ms. Parker and Ms. Ramasastry. Dr. Dilly served as a member of the Audit Committee prior to Ms. Parker's appointment. Director compensation table shows total compensation of $137,060. |
| 2016-04-25 | Stephen G. Dilly, M.B.B.S., Ph.D., age 56, has served as a member of our Board of Directors since March 2010. ... The Clinical Review Committee currently consists of three directors: Dr. Dilly, Dr. Mento and Mr. Lanphier. Dr. Dilly serves as the Chairman of this committee. ... In June 2015 Ms. Parker was appointed to serve on the Audit Committee and she replaced Dr. Dilly and Dr. Mento, who served as members of the Audit Committee prior to her appointment. ... Stephen G. Dilly Fees Earned or Paid in Cash ($) 60,000, Option Awards ($) 65,223, Total ($) 125,223. |
| 2017-04-25 | Stephen G. Dilly, M.B.B.S., Ph.D., age 57, has served as a member of our Board of Directors since March 2010... The Clinical Review Committee consisted of three directors: Dr. Dilly, Dr. Macrae and Dr. Mento. Dr. Dilly served as the Chairman of this committee. |
| 2019-04-25 | Stephen G. Dilly, M.B.B.S., Ph.D., age 59, has served as a member of our Board of Directors since March 2010. The Nominating and Corporate Governance Committee consists of Dr. Dilly, Ms. Parker and Dr. Jeffs. Director compensation table shows total compensation of $235,270. |
Data sourced from SEC filings. Last updated: 2026-02-03